DD115659A5 - - Google Patents

Info

Publication number
DD115659A5
DD115659A5 DD182648A DD18264874A DD115659A5 DD 115659 A5 DD115659 A5 DD 115659A5 DD 182648 A DD182648 A DD 182648A DD 18264874 A DD18264874 A DD 18264874A DD 115659 A5 DD115659 A5 DD 115659A5
Authority
DD
German Democratic Republic
Application number
DD182648A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed filed Critical
Publication of DD115659A5 publication Critical patent/DD115659A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
DD182648A 1973-11-30 1974-11-28 DD115659A5 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
DD115659A5 true DD115659A5 (enExample) 1975-10-12

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
DD182648A DD115659A5 (enExample) 1973-11-30 1974-11-28

Country Status (14)

Country Link
US (1) US4045574A (enExample)
JP (1) JPS5084561A (enExample)
AT (1) AT347611B (enExample)
CA (1) CA1030522A (enExample)
CH (1) CH618183A5 (enExample)
DD (1) DD115659A5 (enExample)
DK (1) DK134348C (enExample)
ES (1) ES432106A1 (enExample)
FR (1) FR2253512B1 (enExample)
GB (1) GB1494097A (enExample)
IE (1) IE40423B1 (enExample)
IL (1) IL46153A (enExample)
NL (1) NL7415577A (enExample)
SE (1) SE408426B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
DE60308388T2 (de) * 2002-08-16 2007-09-20 Pharmacia & Upjohn Co. Llc, Kalamazoo 5-Androsten-3beta-ol-Steroide und Verfahren für ihre Herstellung
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US9365611B2 (en) 2013-04-17 2016-06-14 Sage Therapeutics, Inc. 19-NOR neuroactive steroids and methods of use thereof
KR20230172622A (ko) 2013-04-17 2023-12-22 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3488852T (pt) 2013-08-23 2021-02-03 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
JP7049313B2 (ja) 2016-07-11 2022-04-06 セージ セラピューティクス, インコーポレイテッド C17、c20、およびc21置換神経刺激性ステロイドおよびそれらの使用方法
WO2019126761A1 (en) * 2017-12-22 2019-06-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
BR112021010996A2 (pt) 2018-12-05 2021-08-31 Sage Therapeutics, Inc. Esteroides neuroativos e seus métodos de uso
CA3125675A1 (en) 2019-01-08 2020-07-16 Chengdu kanghong pharmaceutical co ltd Steroid compounds, uses and process for preparation therefor
BR112021024033A2 (pt) 2019-05-31 2022-02-08 Sage Therapeutics Inc Esteroides neuroativos e suas composições
US20230085354A1 (en) * 2019-06-27 2023-03-16 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
CA1030522A (en) 1978-05-02
NL7415577A (nl) 1975-06-03
FR2253512A1 (enExample) 1975-07-04
ES432106A1 (es) 1976-11-01
IE40423B1 (en) 1979-05-23
JPS5084561A (enExample) 1975-07-08
CH618183A5 (enExample) 1980-07-15
SE408426B (sv) 1979-06-11
DK134348C (da) 1977-03-21
FR2253512B1 (enExample) 1978-02-03
GB1494097A (en) 1977-12-07
AU7586774A (en) 1976-06-03
SE7414960L (enExample) 1975-06-02
DK604174A (enExample) 1975-07-28
DK134348B (da) 1976-10-25
IL46153A (en) 1979-01-31
IL46153A0 (en) 1975-02-10
ATA950774A (de) 1978-05-15
IE40423L (en) 1975-05-30
US4045574A (en) 1977-08-30
AT347611B (de) 1979-01-10

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
AU474838B2 (enExample)
FR2253512A1 (enExample)
AU471343B2 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU466283B2 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AR199451A1 (enExample)
AU477823B2 (enExample)
AU471461B2 (enExample)
AR195948A1 (enExample)
AR200256A1 (enExample)
AR201432A1 (enExample)
AR200885A1 (enExample)